These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 15219287

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Development and biodistribution of 188Re-SSS lipiodol following injection into the hepatic artery of healthy pigs.
    Garin E, Noiret N, Malbert C, Lepareur N, Roucoux A, Caulet-Maugendre S, Moisan A, Lecloirec J, Herry JY, Bourguet P.
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):542-6. PubMed ID: 14691613
    [Abstract] [Full Text] [Related]

  • 3. 188Re-SSS lipiodol: radiolabelling and biodistribution following injection into the hepatic artery of rats bearing hepatoma.
    Garin E, Denizot B, Noiret N, Lepareur N, Roux J, Moreau M, Herry JY, Bourguet P, Benoit JP, Lejeune JJ.
    Nucl Med Commun; 2004 Oct; 25(10):1007-13. PubMed ID: 15381868
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model.
    Paeng JC, Jeong JM, Yoon CJ, Lee YS, Suh YG, Chung JW, Park JH, Chung JK, Son M, Lee MC.
    J Nucl Med; 2003 Dec; 44(12):2033-8. PubMed ID: 14660730
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preparation of 166Ho-oxine-lipiodol and its preliminary bioevaluation for the potential application in therapy of liver cancer.
    Das T, Chakraborty S, Sarma HD, Venkatesh M, Banerjee S.
    Nucl Med Commun; 2009 May; 30(5):362-7. PubMed ID: 19282794
    [Abstract] [Full Text] [Related]

  • 9. A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma.
    Boschi A, Uccelli L, Duatti A, Colamussi P, Cittanti C, Filice A, Rose AH, Martindale AA, Claringbold PG, Kearney D, Galeotti R, Turner JH, Giganti M.
    Nucl Med Commun; 2004 Jul; 25(7):691-9. PubMed ID: 15208496
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lipiodol solution of a lipophilic agent, (188)Re-TDD, for the treatment of liver cancer.
    Jeong JM, Kim YJ, Lee YS, Ko JI, Son M, Lee DS, Chung JK, Park JH, Lee MC.
    Nucl Med Biol; 2001 Feb; 28(2):197-204. PubMed ID: 11295430
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development of 99mTc labelled Lipiodol: biodistribution following injection into the hepatic artery of the healthy pig.
    Garin E, Noiret N, Malbert CH, Lepareur N, Roucoux A, Dazord L, Caulet-Maugendre S, Turlin B, Moisan A, Lecloirec J, Herry JY, Boucher E, Raoul JL, Bourguet P.
    Nucl Med Commun; 2004 Mar; 25(3):291-7. PubMed ID: 15094449
    [Abstract] [Full Text] [Related]

  • 15. Advantage of 188Re-radiopharmaceuticals in hepatocellular cancer and liver metastases.
    Liepe K, Kotzerke J, Lambert B.
    J Nucl Med; 2005 Aug; 46(8):1407-8; author reply 1407-8. PubMed ID: 16085601
    [No Abstract] [Full Text] [Related]

  • 16. Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma.
    Uccelli L, Pasquali M, Boschi A, Giganti M, Duatti A.
    Nucl Med Biol; 2011 Feb; 38(2):207-13. PubMed ID: 21315276
    [Abstract] [Full Text] [Related]

  • 17. 186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats.
    Bao A, Goins B, Klipper R, Negrete G, Phillips WT.
    J Nucl Med; 2003 Dec; 44(12):1992-9. PubMed ID: 14660726
    [Abstract] [Full Text] [Related]

  • 18. Biodistribution of rhenium-188 Lipiodol infused via the hepatic artery of rats with hepatic tumours.
    Wang SJ, Lin WY, Chen MN, Hsieh BT, Shen LH, Tsai ZT, Ting G, Knapp FF.
    Eur J Nucl Med; 1996 Jan; 23(1):13-7. PubMed ID: 8586096
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and application of 188Re-MN-16ET/Lipiodol in a hepatocellular carcinoma animal model.
    Tang IC, Luo TY, Liu SW, Chan SH, Kung HC, Peng CL, Lin WY, Chang Y, Lin WJ.
    Nucl Med Biol; 2011 Oct; 38(7):1043-52. PubMed ID: 21831647
    [Abstract] [Full Text] [Related]

  • 20. Biokinetic and dosimetric studies of 188Re-hyaluronic acid: a new radiopharmaceutical for treatment of hepatocellular carcinoma.
    Meléndez-Alafort L, Nadali A, Zangoni E, Banzato A, Rondina M, Rosato A, Mazzi U.
    Nucl Med Biol; 2009 Aug; 36(6):693-701. PubMed ID: 19647176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.